Examinant per Autoria "GELTAMO Group"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy(Elsevier, 2019) Salar Silvestre, Antonio; Jiménez-Ubieto, Ana; Lahuerta, Juan José; GELTAMO Group
Ítem Accés Obert Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.(Springer Verlag, 2016) González-Barca, E.; Canales, M.; Salar Silvestre, Antonio; Ferreiro-Martínez, J. J.; Ferrer-Bordes, S.; García-Marco, J. A.; Sánchez-Blanco, J. J.; García-Frade, Javier; Peñalver, Francisco-Javier; Bello-López, J. L.; Sancho, José María; Caballero, Dolores; GELTAMO Group
Ítem Accés Obert Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series(Springer, 2018) Bobillo, Sabela; Abrisqueta, Pau; Sanchez Gonzalez, Blanca; Giné, Elena; Romero, S.; Alcoceba, Miguel; González-Barca, E.; González de Villambrosía, Sonia; Sancho, José María; Gómez, P.; Bento, M.; Montoro, Julia; Montes, S.; López, Andrés; Bosch, Fatima; GELTAMO Group
Ítem Accés Obert Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma(Wiley, 2017) Jiménez-Ubieto, Ana; Salar Silvestre, Antonio; Lahuerta, Juan José; GELTAMO Group
Ítem Accés Obert Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular Llymphoma after first-line immunochemotherapy: results of the RBMDGELTAMO08 phase II trial(Wiley, 2019) Peñalver, Francisco-Javier; Márquez, José-Antonio; Durán, Soledad; Giraldo, Pilar; Martin, Alejandro; Montalbán, Carlos; Sancho, Juan Manuel; Ramírez, María-José; Terol, María-José; Capote, Francisco-Javier; Gutiérrez, Antonio; Sánchez González, Blanca; López, Andrés; Salar Silvestre, Antonio; Rodríguez-Caravaca, Gil; Canales, M.; Caballero, María Dolores; GELTAMO Group
Ítem Accés Obert Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting(Wiley, 2023) Muntañola, Ana; Arguiñano-Pérez, José María; Dávila, Julio; González de Villambrosía, Sonia; Carpio, Cecilia; Jiménez-Ubieto, Ana; Salar Silvestre, Antonio; GELTAMO Group
Ítem Accés Obert SEGHI study: defining the best surveillance strategy in Hodgkin lymphoma after first-line treatment(MDPI, 2021) Bastos Oreiro, Mariana; Sánchez González, Blanca; GELTAMO Group